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ÖZ
Sekonder psödohipoaldosteronizm (PHA), böbrek tübüllerinin 
aldosterona duyarsızlığı ile karakterize, hiperkalemi, 
hiponatremi ve metabolik asidoz ile kendini gösteren nadir 
bir durumdur. Obstrüktif üropatisi olan bebeklerde ve 
piyelonefrit sırasında görülebilir. Gelişimi devam eden erken 
bebeklik dönemi böbreği, üriner sistemin obstrüktif anomalisi 
ve enfeksiyonu sekonder PHA hastalarında tübüluslarda 
aldosteron direncine neden olan üç önemli faktördür. Genellikle 
hiponatremi, hiperkalemi ve metabolik asidoz ilk bulgulardır, 
tetkiklerde belirgin olarak yükselmiş plazma renin ve aldosteron 
seviyelerinin saptanması ile tanı konur. Süt çoçuklarında 
biyokimyasal incelemede hiperpotasemi, hiponatremi ve 
metabolik asidoz saptandığında konjenital adrenal hiperplazi 
ayırıcı tanısında PHA göz önünde bulundurulmalı ve bu 
hastalarda üriner ultrasonografisi (USG) ve idrar analizi rutin 
olarak yapılmalıdır. Bu yazımızda sekonder PHA gelişen 
posterior üretral valv (PUV)‘lı iki hasta sunuldu.
Anahtar kelimeler: Obstrüktif üropati, Sekonder 
psödohipoaldosteronizm, Süt çocuğu
Introduction
Pseudohypoaldosteronism (PHA) is a clinical condition 
characterized by hyponatremia, hyperkalemia, and 
metabolic acidosis, which develops due to unresponsiveness 
to aldosterone in renal tubular cells. It is classified in two 
forms as Type 1 (PHA1), and Type 2 (PHA2). Type 1 PHA 
may result from primary (genetic) or secondary (acquired) 
causes. In primary PHA1, dysfunction in kidneys and 
also in other epithelial sodium channel (ENaC)-involving 
organs (colon, salivary and sweat glands) occurs due to a 
congenital disorder in ENaC or mineralocorticoid receptors. 
PHA2, which is accompanied by hyperkalemia and 
hypertension, is also called Gordon syndrome or familial 
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Salt wasting in two neonates with posterior urethral valves: secondary 
pseudohypoaldosteronism
Posterior üretral valvlı iki yenidoğanda tuz kaybı: sekonder psödohipoaldosteronizm
ABSTRACT
Secondary pseudohypoaldosteronism (PHA) is a rare condition 
that presents with hyperkalemia, hyponatremia, and metabolic 
acidosis, which develops due to renal tubular unresponsiveness 
to aldosterone. It may be seen in infants with obstructive 
uropathy and acute pyelonephritis. Three important reasons of 
the aldosterone unresponsiveness of the tubules are early infancy 
kidney, obstructive uropathy, and urinary tract infection. Besides 
other findings, diagnosis is established with highly increased 
plasma aldosterone and renin levels. In infants who present with 
hyperkalemia, hyponatremia, and metabolic acidosis, PHA should 
be considered in the differential diagnosis of congenital adrenal 
hyperplasia. Urinary ultrasonography and urine analysis should be 
performed in these patients. Herein, we present two patients with 
secondary PHA caused by posterior urethral valves.
Keywords: Obstructive uropathy, Secondary 
pseudohypoaldosteronism, Infant
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hyperkalemic hypertension (FHHt), and the disease has an 
autosomal dominant (AD) transition [1, 2]. Renal tubular 
cells have transient aldosterone resistance in secondary 
PHA1 and early infant period, urinary tract infections (UTI) 
and congenital anomalies of the kidney and urinary tract 
(CAKUT) are the main risk factors for secondary PHA1.
In the present study, we present two patients who 
underwent valve resection due to posterior urethral valve 
(PUV) and who developed secondary PHA1. We aimed 
to emphasize secondary PHA1 in differential diagnosis of 
hyponatremia and hyperkalemia detected in patients with 
obstructive uropathy.
Case-reports
Case-report 1
Oligohydramnios and bilateral hydronephrosis were 
detected in the antenatal ultrasonography (USG) of a 10-day-
old infant who was delivered through cesarean section in 
week 35 of pregnancy with a birth weight of 2720 g. The 
physical development was normal, blood pressure was 
80/50 mm Hg, heart rate was 120 /min, and genitourinary 
and other system examinations were normal; however, the 
infant had difficulty in urinating and interrupted urination. 
Laboratory examinations revealed the complete blood count 
and C-reactive protein level (CRP) as normal. Creatinine 
was 1.9 mg/dL, potassium 7 mEq/L, and sodium 144 
mE/L. Urine analysis and microscopic urine examination 
were normal. Blood gas analysis was normal. Urinary 
USG revealed bilateral grade 4 hydroureteronephrosis 
(HUN), and trabeculation on the bladder wall. A cystoscopy 
examination revealed PUV, and the infant underwent valve 
resection on day 10. Voiding cystourethrography (VCUG) 
revealed grade 5 vesicoureteral reflux (VUR) in the right 
ureter. The patient was discharged with antipotassium 
treatment for hyperkalemia and amoxicillin treatment 
for UTI prophylaxis. The follow-up sodium level was 
128 mEq/L, potassium was 5 mEq/L under antipotassium 
treatment, and creatinine was 0.96 mg/dL. Blood gas 
analysis revealed metabolic acidosis. Polyuria developed 
during follow-up. Fractional excretion of sodium (FeNa) 
was high, transtubular potassium gradient (TTKG) was 
low, and aldosterone and renin levels were detected high. 
Cortisol, 17 OH progesterone, and adrenocorticotropic 
hormone (ACTH) were within normal ranges (Table I). 
Congenital adrenal hyperplasia (CAH) was excluded with 
these findings, and the patient was diagnosed as secondary 
PHA1. Sodium bicarbonate treatment for metabolic acidosis 
was started.
The patient, who had recurrent UTI during follow-up, 
required antipotassium and sodium replacement therapy in 
decreasing amounts. The replacement therapy was stopped 
at 9 months; the renin level was detected as normal and the 
aldosterone level was at the upper limit of the normal level. 
Serum sodium and potassium levels were normal at the last 
visit when the patient was 3 years of age although the patient 
did not receive any replacement therapy for 27 months.
Case-report 2
A 7-day-old boy who was born via a normal vaginal delivery 
at 36 weeks, with a birth weight of 3040 g was admitted 
to pediatric nephrology clinic due to oligohydramnios and 
bilateral hydronephrosis which were detected antenatally. 
Physical examination of the baby was normal. Blood 
pressure was 80/50 mm Hg and heart rate was 132 /
min. Genitourinary and other system examinations were 
normal. The patient underwent valve resection in day 10 
after detection of PUV in cystoscopy. The biochemical 
examinations revealed creatinine as 4 mg/dL, sodium 144 
mEq/L, and potassium 7.2 mEq/L. Blood gas and urine 
examinations were normal. FeNa was high, TTTK was 
low, aldosterone and renin levels were detected high (Table 
I). The patient was initiated antipotassium treatment and 
developed hyponatremia during follow-up. Cortisol, 17 
OH progesterone, and ACTH levels were within the normal 
ranges in accordance with the patient’s age (Table I). 
Congenital adrenal hyperplasia was excluded, and secondary 
PHA1 due to obstructive uropathy was diagnosed. Sodium 
replacement therapy was initiated. Valve residue was 
detected in repeat cystoscopy after the development of a 
UTI under amoxicillin prophylaxis, and the valve resection 
was repeated. Voiding cystourethrography revealed bilateral 
grade 5 VUR. Replacement therapy was stopped at 5 month, 
and a repeat examination demonstrated that aldosterone and 
renin levels were declining. Renin and aldosterone levels 
were detected as normal at the last visit when the patient 
was 2.5 years of age. Serum sodium and potassium levels 
were within the normal ranges although the patient did not 
receive replacement therapy for 25 months.
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Discussion
Posterior urethral valve is the most frequent congenital 
anomaly that causes obstructive uropathy in males. The 
disorder develops in the early gestational period and 
causes significant bladder dysfunction and kidney damage 
due to high pressure exposure of the bladder and upper 
urinary system. Obstruction causes glomerular and tubular 
dysfunction, and concentration and acidification ability of 
the tubules are damaged, therefore polyuria, sodium wasting 
in urine and electrolite imbalance develop [3,4]. Asano et al., 
reported that the increased intrarenal pressure in obstructive 
uropathy increases cytokine synthesis and causes tubular 
dysfunction. In addition, the obstruction decreases kidney 
blood flow, and this activates the renin-angiotensin system 
and increases aldosterone levels [5].
Pseudohypoaldosteronism is a clinical condition 
characterized by salt wasting and hyperkalemia due to 
aldosterone resistance in tissues. Early infancy period, 
CAKUT and UTI are three significant factors that cause 
aldosterone resistance in tubules of patients with secondary 
PHA1. Secondary PHA1 may also be classified as Type 
3 PHA (PHA3) and is known as transient PHA1. Various 
anomalies of the urinary system (ureterohydronephrosis, 
ureterocele, ureteropelvic obstruction) may cause secondary 
PHA1. Bogdanović et al., investigated 85 patients with 
secondary PHA1 and reported that 90% of total 93 patients 
with secondary PHA1 were aged younger than three months 
of age. Urinary sytem anomalies accompanied in 90%, 
and UTI was present in approximately 89% of patients. In 
addition, they reported that the rate of PUV was 19% in these 
anomalies [6]. Both patients in our study were aged younger 
than 3 months, they had obstructive uropathies secondary to 
PUV, and UTI accompanied during follow-ups.
Although many diseases cause hyponatremia, 
hyperkalemia, and metabolic acidosis during infancy, 
exclusion of CAH is important in these patients. 
Masculinization in girls, and rapid penis growth in boys 
may be observed in the salt wasting form of CAH. Vomiting 
and dehydratation are detected in both sexes a short while 
after birth. The differential diagnosis of PHA and CAH may 
sometimes be difficult. The literature indicates that these 
patients may frequently be misdiagnosed. Pai et al., initiated 
hydrocortisone and fludrocortisone in 3 infants with CAH 
who were hyponatremic, hyperkalemic, and with symptoms 
of vomiting and severe dehydration. However, the patients 
were diagnosed as PHA when laboratory examinations 
were done, and urinary system anomalies (ureteropelvic 
obstruction, megaureter, double system), and UTI were 
detected [7]. Authors have indicated that adrenal steroids 
were frequently given to the patients with secondary PHA1 
with the initial diagnosis as CAH [7,8].
Contrary to that, Ağladıoğlu et al., first diagnosed their 
patients as having PHA, and they were then diagnosed as 
CAH after ACTH stimulation test and genetic analysis; 
renin aldosterone and basal ACTH levels were found to 
be elevated in two patients in their report [9]. The genital 
Table I: Biochemical and hormonal characteristics of the patients
Case 1 Case 2 Reference ranges
Sodium (mEq/L) 128 135 135 - 145
Potassium (mEq/L) 5* 7.2 3.5 - 4.5
Bicarbonate (mmol/L) 19 21 22 - 26
Plasma renin activity (ng/L) 117 270 3 - 16
Plasma aldosterone activity (pg/mL) 1285 3300 29.4 - 161.5
17 OH progesterone (ng/mL) 1.47 8.1 0.7- 5
ACTH (pg/mL) 45.4 14.8 0 - 46
Cortisol (µg/dL) 17.04 14.5 6.2 - 19.4
FeNa (%) 3 9.7 < 1
TTKG (%) 3 4.8 > 8
Urinary anomaly PUV + VUR PUV + VUR
Urinary tract infection Yes Yes
* During antipotassium treatment, FeNa: Fractional excretion of sodium, TTKG: Transtubular potassium gradient, PUV: Posterior urethral valve, VUR: Ve-
sicoureteral reflux
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examinations of our patients were normal. We thought 
that high levels of potassium during the first presentation 
developed secondary to kidney dysfunction. The patients 
had hyponatremia, metabolic acidosis, and salt wasting 
from urine during follow-up and were diagnosed as having 
secondary PHA1 after the detection of high levels of renin 
and aldosterone levels. Other adrenal hormones and ACTH 
levels were within the normal ranges in both patients. Repeat 
examinations showed that renin and aldosterone levels were 
declining, and no increase was detected in ACTH levels. We 
did not suspect CAH owing to the clinical and laboratory 
data. We did not require a genetic investigation or ACTH 
stimulation test.
Salt wasting and growth retardation are generally 
detected in the neonatal period of patients with primary 
(genetic) PHA1, and the disease has two types. Generalized 
or autosomal recessive (AR) PHA1 develops due to a 
mutation and function loss of EnaC, which is present in 
most organs. The clinical condition is more severe in these 
patients due to salt wasting from the kidneys, colon, salivary 
and sweat glands. However, clinical symptoms are mild, 
and limited to the kidneys in renal or AD PHA1, which 
stems from the NR3C2 gene mutation, which encodes the 
mineralocorticoid receptors. Clinical symptoms become 
milder with age in these patients. Salt replacement is 
generally not required after 2 years of age owing to the 
increase of sodium reabsorption maturation in renal tubules 
with advanced age. Clinical and laboratory findings of 
secondary PHA1 are similar to the findings those are present 
in AD PHA1. Urinary USG and history of UTI are important 
in the differentiation of secondary PHA1 from primary 
PHA1. Bowden et al., diagnosed their patients as having 
AD PHA1 after detection of NRC2 gene mutation, which 
they conducted because although the clinical condition 
improved, a high level of aldosterone was maintained in 
their patients who they first diagnosed as having secondary 
PHA1. The same gene mutation was detected in the patient’s 
mother; however, she was asymptomatic, and hormonal 
examination revealed high level of aldosterone. The author 
emphasized that NR3C2 DNA analysis must be performed 
for patients who maintain high serum level of aldosterone 
after treatment of urinary system anomalies or UTI, and 
patients who present with clinical symptoms of secondary 
PHA1 must be suspected of having primary AD PHA1 [10]. 
In another similar case, an infant with acute pyelonephritis 
was first diagnosed as having secondary PHA1. In this 
baby due to continued high renin and aldosterone levels 
after clinical recovery, the patient’s asymptomatic mother 
and two siblings were investigated and high levels of renin 
and aldosterone were detected. In this case, where genetic 
examination could not be performed, the authors reported 
that although AD PHA1 could be detected as asymptomatic 
in the clinic, the findings of disease could be clinically 
detected with accompanying secondary factors such as 
inflammation, which cause transient tubular dysfunction 
[11]. Replacement therapy was interrupted in month 9 in 
our first case; the renin level was normal and aldosterone 
level was at the upper limit of the normal values in 
repeat hormonal examinations. Replacement therapy was 
interrupted in month 5 in our second case, and high levels of 
renin and aldosterone were maintained in decreasing levels. 
However, renin and aldosteron levels were found normal 
in a repeat examination at 2.5 years of age. None of our 
patients required replacement therapy during their pediatric 
nephrology follow-up, which lasted more than 2 years. We 
did not perform a family investigation because primary 
PHA1 was excluded with clinical and laboratory findings.
In conclusion, secondary PHA1 is a rare clinical 
condition that develops in early infancy. Pediatricians must 
suspect PHA in addition to CAH in infants with salt wasting 
and hyperkalemia, and must perform urinary USG and 
simple urine analysis. Furthermore, serum electrolytes of 
infants who have urinary tract anomalies or infections must 
be closely monitored.
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